MedTrace Logo

Step Rate in Recreational Runners

NCT03057522 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 38

Last updated 2018-11-14

No results posted yet for this study

Summary

This will be a pilot study to determine if a 6 week home training program can increase preferred step rate (cadence) in recreational runners. Increase in step rate has been correlated with decreased stress at lower limb joints in runners. This has the potential of decreasing overuse injuries in this population.

Research participants will have their preferred cadence evaluated at the beginning of the study. The athletes will be randomly assigned to two groups. One group will continue to train without intervention and the other group will train at a cadence of 10% higher than their preferred step rate.

At the end of 6 weeks the participants will have their preferred cadence reevaluated using the same method as pre-participation cadence was determined.

The investigators hypothesis the preferred running cadence of recreational runners following the intervention will be 5-10% greater than prior to the intervention and the increased cadence will be maintained for 6 months following the intervention.

Conditions

  • Gait Disorder, Sensorimotor

Interventions

BEHAVIORAL

Change in running cadence

The intervention will involve a home exercise program designed to increase the running cadence in recreational runners.

Sponsors & Collaborators

Principal Investigators

  • Jonathan T Finnoff · Mayo Clinic

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-02-01
Primary Completion
2018-06-01
Completion
2018-06-01

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03057522 on ClinicalTrials.gov